FORMULATION AND EVALUATION OF ZIDOVUDINE CONTROLLED RELEASE GAS POWERED SYSTEM USING HYDROPHILLIC POLYMER
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2011, Vol 2, Issue 3
Abstract
Zidovudine is the first approved compound for the treatment of AIDS; however the main limitation to therapeutic effectiveness of zidovudine is its dose-dependent toxicity, short biological half-life and poor bioavailability. The present research work an attempt has been made to develop the Zidovudine gas powered drug delivery system for controlled release. The Zidovudine gas powered tablets were prepared by direct compression method by using the different grades of hydrophilic polymer like HPMC. The sodium bicarbonates and citric acid were also used as a gas generating agent. The power blend was subjected for pre-compressional parameters. The prepared gas powered tablets are evaluated to post-compressional analysis of parameter such as hardness, friability, weight variation , thickness, drug content, lag time subsequently buoyancy time and in-vitro dissolution studies and swelling index. All the pre and post-compressional parameter are evaluated the results were within acceptable limits. The results of in-vitro buoyancy time and lag time study, the values of in-vitro buoyancy time ranges from 38 to 960 min where as floating lag time ranges from 3.5 to 60 min. The formulation F4 shows the lag time 3.5 min and buoyancy time 960 min. The results of in-vitro buoyancy time and lag time study revealed that as the concentration of sodium bicarbonate increases there is increase in total buoyancy time and decrease in lag time. It is evident from the in-vitro dissolution data that increase in citric acid concentration increased the release rate but reduced the floating time, probably due to of excess carbon dioxide, disturbing the monolithic tablet. The citric acid level in the formulations greatly influenced the drug release. The formulation, F-4 shows maximum drug release at the end of 12 hrs. Form this study, it is concluded that, the formulation retained for longer periods of time in the stomach and provides controlled release of the drug. Hence it may be increase the therapeutic efficacy of the drug by increasing the bioavailability and patient compliance.
Authors and Affiliations
N. G. Rao, M. Shrishail
Keywords
Related Articles
- EP ID EP129880
- DOI -
- Views 127
- Downloads 0
FORMULATION AND EVALUATION OF BUCCAL TABLET OF SALBUTAMOL SULPHATE
Mucoadhesive tablets containing salbutamol sulphate were prepared using direct compression method. Carbopol 934P, HPMC K4M, and xanthan gum were used as bioadhesive polymer. HPMC K4M and Xanthan gum were used in differen...
PATHOPHYSIOLOGY OF ULCERS AND HERBAL DRUGS USED IN MANAGEMENT OF ULCERS
Peptic ulcer is the most common gastro-intestinal tract disorder (GIT). A number of drugs including proton pump inhibitors and H2 receptor antagonists are available for the treatment of peptic ulcer, but these drugs has...
PREVALENCE OF POLYPHARMACY AND DRUG TO DRUG INTERACTIONS IN A TERTIARY CARE TEACHING HOSPITAL
Drugs are the most common medical interventions for betterment of the patients but they are fatal too. Inappropriate prescription and using of multiple medications can lead to morbidity and mortality. Polypharmacy is an...
THE EFFECT OF pH CONTROL ON THE SOLUBILITY AND PARTITION COEEFICIENT OF TRANDOLAPRIL
The objective of the present study was to investigate the effect of pH control on the aqueous solubility and partition coefficient of trandolapril respectively. The aqueous solubility was determined at 25 ° C using pH va...
QUINAZOLINONE: AN OVERVIEW
Quinazolinone is a heterocyclic compound with a unique place in the field of medicnal chemistry. This quinazolinone has gain importance as antimicrobial, anti-inflammatory, anticonvulsant, analgesic, antihypertensive, an...